BioCentury | Feb 5, 2007
Finance

AIM iceberg

...169% Vectura (LSE:VEC) 6/25/04 £20.0 £60.0 £156.8 161% ReNeuron (LSE:RENE) 8/5/05 £9.5 £23.4 £47.4 103% Oxonica...
BioCentury | Nov 6, 2006
Company News

Oxonica management update

...from president of OXN's America Oxonica Inc. unit; and Sharron Penn to COO of America Oxonica...
BioCentury | Aug 28, 2006
Company News

Oxonica, Becton Dickinson deal

...technology in undisclosed diagnostic indications. BDX will invest $2 million in newly issued OXN stock. Oxonica plc...
BioCentury | Jan 2, 2006
Company News

Nanoplex, Oxonica deal

...company OXN acquired encoded nanoparticle company Nanoplex for an undisclosed sum. Nanoplex will be renamed Oxonica...
...Inc. and will remain in Mountain View, Calif. Nanoplex Technologies Inc. , Mountain View, Calif. Oxonica plc...
BioCentury | Jan 2, 2006
Finance

IPO performance

...1% Abcam (LSE:ABC)(A) 10/28/05 $17.7 $101.6 $147.5 45% ReNeuron (LSE:RENE)(A) 8/5/05 $16.7 $41.1 $37.7 -8% Oxonica...
BioCentury | Oct 3, 2005
Finance

IPO performance

...Company Date Raised Post-IPO 9/30 Mcap Chg ReNeuron (LSE:RENE) (A) 8/5/05 $16.7 $41.1 $40.6 -1% Oxonica...
BioCentury | Jul 25, 2005
Strategy

European IPOs

...$127.1 $131.6 4% Galapagos(Euronext:GLPG) 5/5/05 $27.6 $78.5 $82.3 5% Intercell(VSE:ICLL) 2/25/05 $69.1 $240.3 $278.3 16% Oxonica...
BioCentury | Jun 17, 2002
Finance

Ebb & Flow

...BASF Venture Capital pulled the trigger on its first investment, putting money into nanotech play Oxonica...
...to E100 million ($94.4 million) in 20-30 startups, with a focus on the chemicals industry. Oxonica...
Items per page:
1 - 8 of 8
BioCentury | Feb 5, 2007
Finance

AIM iceberg

...169% Vectura (LSE:VEC) 6/25/04 £20.0 £60.0 £156.8 161% ReNeuron (LSE:RENE) 8/5/05 £9.5 £23.4 £47.4 103% Oxonica...
BioCentury | Nov 6, 2006
Company News

Oxonica management update

...from president of OXN's America Oxonica Inc. unit; and Sharron Penn to COO of America Oxonica...
BioCentury | Aug 28, 2006
Company News

Oxonica, Becton Dickinson deal

...technology in undisclosed diagnostic indications. BDX will invest $2 million in newly issued OXN stock. Oxonica plc...
BioCentury | Jan 2, 2006
Company News

Nanoplex, Oxonica deal

...company OXN acquired encoded nanoparticle company Nanoplex for an undisclosed sum. Nanoplex will be renamed Oxonica...
...Inc. and will remain in Mountain View, Calif. Nanoplex Technologies Inc. , Mountain View, Calif. Oxonica plc...
BioCentury | Jan 2, 2006
Finance

IPO performance

...1% Abcam (LSE:ABC)(A) 10/28/05 $17.7 $101.6 $147.5 45% ReNeuron (LSE:RENE)(A) 8/5/05 $16.7 $41.1 $37.7 -8% Oxonica...
BioCentury | Oct 3, 2005
Finance

IPO performance

...Company Date Raised Post-IPO 9/30 Mcap Chg ReNeuron (LSE:RENE) (A) 8/5/05 $16.7 $41.1 $40.6 -1% Oxonica...
BioCentury | Jul 25, 2005
Strategy

European IPOs

...$127.1 $131.6 4% Galapagos(Euronext:GLPG) 5/5/05 $27.6 $78.5 $82.3 5% Intercell(VSE:ICLL) 2/25/05 $69.1 $240.3 $278.3 16% Oxonica...
BioCentury | Jun 17, 2002
Finance

Ebb & Flow

...BASF Venture Capital pulled the trigger on its first investment, putting money into nanotech play Oxonica...
...to E100 million ($94.4 million) in 20-30 startups, with a focus on the chemicals industry. Oxonica...
Items per page:
1 - 8 of 8